Johanna Lightcap, DPM
Foot & Ankle Surgery · Lewes, DENPI 1164959243
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,250 of the $3,550 with a category attached, or 63.4%. 10 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 43.4% of the total. Reporting peaked in 2022 at $1,263 and has fallen 91.6% since, to $107 in 2025.
Across 20 payments — averaging $177.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$2K
- Medinc Of Texas$1K
- Arthrex$272
- Amgen$220
- Stryker$172
- Averitas Pharma Inc.$114
- plus $180 from 4 others
What the payments were for
- Travel & lodging$52115%
- Food & beverage$77922%
- Education$2,25063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 6 | $1,542 |
| Medinc Of Texas | 2 | $1,050 |
| Arthrex | 4 | $272 |
| Amgen(2 entities) | 2 | $220 |
| Stryker | 1 | $172 |
| Averitas Pharma Inc. | 1 | $114 |
| Mimedx Group, Inc. | 1 | $87 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $49 |
| Integra Lifesciences Corporation | 1 | $24 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,550 in reported general payments places this provider in the 55th percentile of 32 foot & ankle surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 27 | $653 |
| Meloxicam | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lewes
- Brendan KaneLewes$11K
- Roman OrsiniLewes$3K
- Claire CapobiancoLewes$55
- Jacob HanlonDover$50K
- Cody BowersWilmington$14K
- Bradley LemonSeaford$10K
- Kirstyn UrbasNewark$7K
- Korey DuboisWilmington$7K
- Katrin HeinemanWilmington$6K
- Katherine PersckyWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.